BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Total Current Assets
All assets expected to be converted to cash or used up within one year.
BillionToOne, Inc.NASDAQ: BLLN
Total Current Assets · Q2 FY2026 · quarter ended Jun 2026
Total current assets rises 175.8% from a year ago
Total current assets stood at $651.38M at the end of Q2 FY2026, up 175.8% from a year earlier and up 4.4% from the prior quarter.
Context
- Total current assets amounted to 89.3% of total assets at the end of Q2 FY2026, up 13.7 pp from a year earlier.
- Total current assets increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +175.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 560.56M USD
- Year-over-year change
- +146.1%
- 2-year CAGR
- +120.3%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 560.56M | +146.1% |
| FY2024 | 2024-12-31 | 227.82M | +97.2% |
| FY2023 | 2023-12-31 | 115.5M | — |
Total Current Assets vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 total current assets of $651.38M is the 4th highest of the 9 companies compared; the peer median is $526.91M.
- Its year-over-year change of +175.8% is the highest of 9, against a peer median of +18.1%.
- Total current assets amounts to 89.3% of total assets for BLLN, versus a peer median of 43.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.66B | +15.9% | +7.3% | 62.4% | |
| Sep 2026 | $1.34B | +62.1% | +7.2% | 71.2% | |
| Jun 2026 | $914.72M | +40.3% | +47.8% | 32.2% | |
BLLNBillionToOne, Inc. | Jun 2026 | $651.38M | +175.8% | — | 89.3% |
| Jun 2026 | $574.78M | +38.6% | +25.2% | 38.7% | |
| Mar 2026 | $479.04M | +14.9% | -4.3% | 41.4% | |
| Jun 2026 | $381.48M | -2.8% | -14.7% | 28.2% | |
| Mar 2026 | $312.8M | +8.9% | +6.6% | 46.4% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $246.36M | +20.3% | +8.1% | 51.2% |
| Peer median (excluding BLLN) | $526.91M | +18.1% | +7.2% | 43.9% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.